ATSN-201

N/A

Report date: 2026/05/02 20:00:18

Base Information

Drug NameATSN-201
Drug Alias NameATSN-201
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionRetinoschisin gene transference
TargetsRetinoschisin
Therapy Area/IndicationsRetinoschisis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAtsena Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesAtsena Therapeutics
Inactive CompaniesN/A
Active IndicationsRetinoschisis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A